| Mrs Denise Helene Szott, CCC-SLP/L | |
|
3105 N Wilke Rd, Arlington Heights, IL 60004-1495 | |
| (847) 255-8690 | |
| Not Available |
| Full Name | Mrs Denise Helene Szott |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3105 N Wilke Rd, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346432085 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146.008098 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Denise Helene Szott, CCC-SLP/L 3105 N Wilke Rd, Arlington Heights, IL 60004-1495 Ph: () - | Mrs Denise Helene Szott, CCC-SLP/L 3105 N Wilke Rd, Arlington Heights, IL 60004-1495 Ph: (847) 255-8690 |
News Archive
A small clinical trial of patients with multiple sclerosis (MS) who did not respond to interferon alone found that adding the human antibody daclizumab improved patient outcome. Patients who received the combined therapy had a 78 percent reduction in new brain lesions and a 70 percent reduction in total lesions, along with other significant clinical improvements.
The creation and sustainment of "safe spaces" may play a critical role in community-based HIV prevention efforts by providing social support and reducing environmental barriers for vulnerable populations, a new study from an Oregon State University researcher has found.
People who have been diagnosed with a mild concussion, or mild traumatic brain injury, may have a 56 percent increased risk of developing Parkinson's disease, according to a study published in the April 18, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies for acute, life-threatening neurological conditions, today announced that it has initiated patient enrollment in the second cohort of the NEWTON study, a multicenter, randomized, controlled, open-label, Phase 1/2 clinical trial of the company's lead product candidate, EG-1962.
Northwestern Medicine scientists have discovered a cell in the retina that may cause myopia when it dysfunctions. The dysfunction may be linked to the amount of time a child spends indoors and away from natural light.
› Verified 2 days ago
Mrs. Megan Brazas, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 705 W Maude Ave, Arlington Heights, IL 60004 Phone: 630-329-2389 | |
Mrs. Gloria S Vosburgh, M. ED. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 E Ivy Ln, Arlington Heights, IL 60004 Phone: 847-253-9470 | |
Christine Anne Loprest, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2211 N Burke Dr, Arlington Heights, IL 60004 Phone: 847-398-4275 | |
Judith Ildiko Jokay, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1315 E Miner St, Arlington Heights, IL 60004 Phone: 847-398-4297 | |
Miss Aimee Rose Leblanc, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Dunton Ave, Arlington Heights, IL 60005 Phone: 847-758-7958 | |
Amy Leigh Sarna, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2121 S Goebbert Rd, Arlington Heights, IL 60005 Phone: 847-718-4965 | |
Julie M. Wyss, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 W Central Rd, Arlington Heights, IL 60005 Phone: 847-506-3482 |